Europe Research Roundup: BMW, Royal Bank Of Scotland, Hugo Boss, Hermes

Financiere de Tubize SA

21/03/2014 15:06

March 21 (Reuters) - Securities analysts revised their ratings and price targets on several 
European companies, including Hikma Pharmaceuticals and Zealand Pharma, on Friday.  
     
    HIGHLIGHTS 
    * Hikma Pharmaceuticals  HIK.L : Jefferies cuts to hold from buy rating  
    * Zealand Pharma  ZELA.CO : Jefferies cuts target price to Dkk 110 from Dkk 115; rating buy 
       
Following is a summary of research actions on European companies reported by Reuters on Friday. 
Stock entries are in alphabetical order.    
     
    * Dogus Otomotiv  DOAS.IS : Renaissance Capital cuts target to Tl 10.45 from Tl 13.10; buy  
    * Etalon  ETLNGq.L : Renaissance Capital cuts price target to $5.9 from $6.6; rating buy 
    * Ford Otomotiv  FROTO.IS : Renaissance Capital cuts target to Tl 21 from Tl 28.20; hold  
    * Hikma Pharmaceuticals  HIK.L : Jefferies cuts to hold from buy rating  
    * Intu Properties  INTUP.L : Jefferies cuts target price to 270p from 344p; rating hold 
    * Tofas Turk Otomobil  TOASO.IS : Renaissance Cuts target to Tl 11.45 from Tl 13.90; hold  
    * Zealand Pharma  ZELA.CO : Jefferies cuts target price to Dkk 110 from Dkk 115; rating buy 
 
  
 
 (Compiled by Rachel Chitra in Bangalore) 
 ((rachel.chitra@thomsonreuters.com)(within U.S. +1 646 223 8780)(outside U.S. +91 80 
67496149)(Reuters Messaging: rachel.chitra.reuters.com@reuters.net)) 
 
Keywords: RESEARCH EUROPE/